Royalty Pharma
RPRX
$28.07
Share price
-1.09%
Change (1 day)
-18.23%
Change (1 year)
Categories
Market capitalization of Royalty Pharma (RPRX)
Market cap: $16.95 Billion
As of May 2024 Royalty Pharma has a market cap of $16.95 Billion. This makes Royalty Pharma the world's 1098th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Royalty Pharma from 2020 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $16.95 B | 0.67% |
| 2023 | $16.84 B | -3.38% |
| 2022 | $17.43 B | 1.85% |
| 2021 | $17.11 B | -11.89% |
| 2020 | $19.42 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of Royalty Pharma was reported to be:
$16.77 Billion
$16.77 Billion
$16.77 Billion
$12.66 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $182.26 B | 974.96% | 🇺🇸 USA |
 Eli Lilly LLY | $726.09 B | 4,182.39% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $1.41 B | -91.67% | 🇺🇸 USA |